LifeMD Inc Preferred Series A (LFMDP) support and resistance · rev $212.5M
LifeMD Inc Preferred Series A (LFMDP) is a health information services company listed on US.
This page maps LifeMD Inc Preferred Series A (LFMDP) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported LFMDP revenue for 2024-12-31 was $212.5M. Net income was -$18.7M. Revenue was up 39.3% from 2023-12-31 to 2024-12-31. LFMDP currently screens at market cap $0.
LFMDP currently screens at market cap $0. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new LFMDP 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the LFMDP quote page for the session range and the stock page for the full model.
Not investment advice.